Do you routinely stop ESA when starting myelofibrosis patients on JAK inhibitor therapy?
Community PollStarted
Do you typically use ESAs with momelotinib?
11 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Hematology · University of Chicago
Answered on
The management of myelofibrosis with anemia is becoming increasingly nuanced, given the several JAK inhibitors available to us and the potential for add-on therapies! An excellent resource to consider regarding decision-making is Jain et al., PMID 39808793. Regarding this specific question at hand, ...
Join for free or sign in to see the full answer